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Abstract
Key message The potent anti-HIV microbicide griffithsin was expressed to high levels in tobacco chloroplasts, ena-
bling efficient purification from both fresh and dried biomass, thus providing storable material for inexpensive 
production and scale-up on demand.
Abstract The global HIV epidemic continues to grow, with 1.8 million new infections occurring per year. In the absence of a 
cure and an AIDS vaccine, there is a pressing need to prevent new infections in order to curb the disease. Topical microbicides 
that block viral entry into human cells can potentially prevent HIV infection. The antiviral lectin griffithsin has been identified 
as a highly potent inhibitor of HIV entry into human cells. Here we have explored the possibility to use transplastomic plants 
as an inexpensive production platform for griffithsin. We show that griffithsin accumulates in stably transformed tobacco 
chloroplasts to up to 5% of the total soluble protein of the plant. Griffithsin can be easily purified from leaf material and shows 
similarly high virus neutralization activity as griffithsin protein recombinantly expressed in bacteria. We also show that dried 
tobacco provides a storable source material for griffithsin purification, thus enabling quick scale-up of production on demand.
Keywords Plastid transformation · Nicotiana tabacum · Molecular farming · HIV · AIDS · Antiviral agent · Microbicide · 
Griffithsin · Chloroplast
Introduction
The global human immunodeficiency virus (HIV) epidemic 
continues to grow, with more than 36.7 million people now esti-
mated to carry the virus (UNAIDS Report 2017: http://www.
unaid s.org/en/resou rces/docum ents/2017/2017_data_book). 
Although global scale-up of antiretroviral therapy has recently 
resulted in a substantial decline in deaths from AIDS-related 
causes, HIV was still responsible for approximately a mil-
lion deaths in 2016. At the same time, 1.8 million new infec-
tions occur per year, resulting in a continuous net increase in 
infected individuals (UNAIDS Report 2017: http://www.unaid 
s.org/en/resou rces/docum ents/2017/2017_data_book). In the 
absence of a cure that would eliminate the virus, it is therefore 
of utmost importance to reduce the number of new infections. 
Unfortunately, despite enormous efforts to develop immuniza-
tion strategies against HIV, an AIDS vaccine is currently not 
in sight (Levine 2008; Virgin and Walker 2010; Haase 2010; 
Andrabi et al. 2018). Topical (vaginal and rectal) microbicides 
that potentially prevent new infections, therefore, represent one 
of the most promising strategies to control the disease (Boyd 
et al. 1997; Lederman et al. 2004; Mori et al. 2005; Veazey 
et al. 2005; Rao et al. 2005; Vanpouille et al. 2012; O’Keefe 
et al. 2015).
Inhibitors that block entry of the virus into human cells 
are particularly suitable to prevent infection (Lederman et al. 
2004; Veazey et al. 2005). Large-scale screens for peptides, 
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proteins and small molecules that act as virus-cell fusion 
inhibitors have been conducted and a number of candidate 
molecules have been identified. One of the first potent anti-
viral agents that was found to bind to the HIV surface and 
block viral entry into cells was cyanovirin-N (CV-N), a 
small protein (11 kDa) of the cyanobacterium Nostoc ellip-
sosporum (Boyd et al. 1997). It binds irreversibly to the 
surface envelope glycoprotein gp120 by targeting N-linked 
high-mannose oligosaccharides (Botos et al. 2002; Bewley 
et al. 2002; Barrientos and Gronenborn 2002) and, in this 
way, blocks binding of the virus to its receptors on host cells. 
Recombinant production of CV-N has been attempted in sev-
eral systems, including bacteria, transgenic plants and trans-
plastomic plants, but protein yields have been relatively low 
(Colleluori et al. 2005; Sexton et al. 2006; Gao et al. 2010; 
Elghabi et al. 2011; O’Keefe et al. 2015).
An even more potent small protein with a similar mode 
of action is the 12.7 kDa lectin griffithsin from the red alga 
Griffithsia sp. (Mori et al. 2005; Kouokam et al. 2011). 
While CV-N is active against HIV at low nanomolar con-
centrations, griffithsin displays anti-viral activity against all 
isolates of HIV already at picomolar concentrations (Mori 
et al. 2005; O’Keefe et al. 2009), thus making griffithsin 
a highly attractive candidate microbicide to prevent sexual 
transmission of the virus. In addition to its high specific 
activity against HIV, griffithsin is also extremely resist-
ant to physicochemical degradation and shows high safety 
(Kouokam et al. 2011). Preclinical development of griffith-
sin as a potential vaginal microbicide for prevention of HIV 
transmission is currently underway. Interestingly, griffithsin 
also displays strong affinity to the envelope glycoproteins of 
other highly pathogenic viruses, such as the SARS coronavi-
rus (SARS-CoV), hepatitis C virus (HCV) and Ebola virus 
(O’Keefe et al. 2010; Barton et al. 2014).
Development of griffithsin as an affordable anti-HIV 
microbicide will require inexpensive mass production of the 
protein, ideally from a renewable source and not requiring 
expensive fermentation procedures. Plants represent a par-
ticularly cheap, readily scalable and safe production platform 
for biopharmaceuticals (Ma et al. 2005; Daniell et al. 2009; 
Rybicki 2010; Marusic et al. 2009; Bock 2014, 2015; Wong-
Arce et al. 2017). Therefore, extensive efforts have been 
made to develop technologies that enable high-level expres-
sion of recombinant proteins in plants, including antibodies, 
antigens for subunit vaccines and microbicides. Expression 
of griffithsin has been tested in several expression systems, 
including viral vector-based transient expression in tobacco 
leaves (O’Keefe et al. 2009; Hahn et al. 2015; Fuqua et al. 
2015a, b) and stable transgenic expression in rice seeds 
(Vamvaka et al. 2016). While transient expression systems 
often give high expression levels, they incur additional costs 
due to the need to transfect each new batch of plant material. 
By contrast, in stable transgenic plants, the starting material 
for purification can be provided at the (very low) cost of 
the biomass. Also, stable transgenic plants provide greater 
batch-to-batch consistency than transiently transfected plant 
material (Fujiuchi et al. 2016).
Transgene expression from the plastid (chloroplast) 
genome offers a number of highly attractive features, includ-
ing precise transgene insertion by homologous recombi-
nation, absence of epigenetic gene silencing, and greatly 
increased transgene confinement due to maternal inherit-
ance of plastids and their efficient exclusion from pollen in 
most crops (Maliga 2004; Ruf et al. 2007; Bock 2015). The 
greatest attraction for molecular farming applications lies 
in the potential of chloroplast-transformed (transplastomic) 
plants to accumulate extraordinarily high levels of foreign 
proteins, often one to three orders of magnitude higher than 
what is possible to achieve by nuclear transgenesis (De Cosa 
et al. 2001; Tregoning et al. 2003; Molina et al. 2004; Zhou 
et al. 2008; Oey et al. 2009a, b). However, it is important to 
note that, while there are numerous cases of spectacularly 
high expression levels achieved in transplastomic plants, not 
all foreign proteins accumulate stably in transgenic chloro-
plasts. Unfortunately, the rules governing protein stability 
in plastids are only poorly understood (Apel et al. 2010; De 
Marchis et al. 2012) and, thus, predictions about the suc-
cess of recombinant protein accumulation in chloroplasts 
are currently hardly possible. For example, transplastomic 
expression of CV-N in tobacco was undetectably low, but 
could be improved by fusion to N-terminal and C-terminal 
sequences taken from proteins known to be very stable in 
plastids (Elghabi et al. 2011). Nonetheless, CV-N accumu-
lation levels reached only 0.3% of the total soluble protein 
(TSP), a value that is two orders of magnitude below the lev-
els attained with PlyGBS, one of the proteins whose N- and 
C-terminal sequences were used for stabilization of CV-N 
(Oey et al. 2009a; Elghabi et al. 2011).
Here we have explored the possibility to express grif-
fithsin in tobacco chloroplasts. Although CV-N and griffith-
sin are similar in size and have a similar mode of antiviral 
action, their primary sequences are very different. Also, 
CV-N is a prokaryotic (cyanobacterial) protein, while grif-
fithsin is of eukaryotic (red algal) origin. Thus, the two pro-
teins likely evolved different (in)stability determinants which 
may have different effects on their stability in the chloroplast 
(representing a prokaryotic system). Expression of griffithsin 
from the chloroplast genome was attempted recently (Vafaee 
et al. 2014), but no accumulation levels were reported and 
no purification and activity tests were performed. We report 
here that griffithsin can be expressed to very high levels 
(of approximately 5% of the plant’s total soluble protein) 
in tobacco chloroplasts and has similar anti-HIV activity as 
the recombinant protein produced in bacteria. We also show 
that, due to its enormous thermal stability, (i) griffithsin can 
be very easily purified from leaf biomass, (ii) high levels of 
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intact protein can be extracted from dried leaves, and (iii) 
griffithsin isolated from dry tobacco retains high antiviral 
activity.
Materials and methods
Plant material and growth conditions
Sterile tobacco (Nicotiana tabacum cv. Petit Havana) plants 
were grown on agar-solidified MS medium (Murashige and 
Skoog 1962) containing 30 g/L sucrose. For seed production 
and generation of material for molecular analyses, plants 
were transferred to soil and cultivated under standard green-
house conditions. For inheritance assays, seeds were surface 
sterilized and sown on agar-solidified MS medium contain-
ing 20 g/L sucrose and the appropriate antibiotics for selec-
tion (spectinomycin: 500 mg/L, gentamycin: 200 mg/L).
To investigate the recovery of griffithsin from dry 
tobacco, leaves were harvested from greenhouse-grown 
plants, dried between tissue paper for approximately 
4 months at room temperature, followed by initial tests for 
the presence of griffithsin and subsequent storage in sealed 
containers at room temperature until 10 months after har-
vest, followed by protein purification.
Cloning procedures
The griffithsin nucleotide sequence (accession number 
AY744144; Mori et al. 2005) including the sequence for 
an N-terminal histidine tag was codon-optimized for the 
tobacco chloroplast genome and chemically synthesized 
(Epoch Life Science, Missouri City, TX; http://www.epoch 
lifes cienc e.com/). The synthetic grft gene was inserted as 
NdeI/XbaI fragment into cloning vector pHK20 (Kuroda and 
Maliga 2001) where it is driven by the plastid rRNA operon 
promoter fused to the gene10 leader sequence of bacterio-
phage T7. The griffithsin cassette was subsequently excised 
as SacI/HindIII fragment and cloned into the similarly cut 
plasmid pKP9 (Zhou et al. 2008), generating the final trans-
formation vector pGrft1.
Chloroplast transformation
Young tobacco leaves were bombarded with vector pGrft1 
coated onto gold particles (0.6 µm diameter) using a helium-
driven biolistic gun (PDS-1000He; Bio-Rad). Primary trans-
formants were selected on regeneration medium containing 
500 mg/L spectinomycin (Svab and Maliga 1993) and sub-
sequently subjected to two additional rounds of regeneration 
on spectinomycin-containing medium to select against resid-
ual copies of the wild-type plastid genome. Spontaneous 
spectinomycin-resistant lines were eliminated by double 
selection on medium containing both spectinomycin and 
streptomycin (500 mg/L each; Svab and Maliga 1993; Bock 
2001). Homoplasmic transplastomic plantlets were rooted 
on hormone-free medium and then transferred to the green-
house for seed production.
Selectable marker gene removal
For marker elimination, homoplasmic transplastomic 
plants were crossed to nuclear-transgenic plants expressing 
a plastid-targeted Cre recombinase (Corneille et al. 2001). 
The resulting seeds were surface sterilized and cultivated 
on MS medium containing 20 g/L sucrose and 500 mg/L 
spectinomycin. White seedlings were transferred to antibi-
otic-free medium and, after greening and continued growth, 
transferred to the greenhouse. To also eliminate the nuclear 
marker gene, plants were pollinated with wild-type pollen. 
The progeny from these crosses was used for protein purifi-
cation experiments.
Isolation of nucleic acids and gel blot analyses
Total plant DNA was extracted by a cetyltrimethylammo-
niumbromide-based method (Doyle and Doyle 1990). Total 
cellular RNA was isolated with the NucleoSpin RNA Plant 
kit (Macherey–Nagel). For RFLP analysis, DNA samples 
(3 µg total DNA) were treated with the restriction enzyme 
BamHI, followed by separation of the fragments by elec-
trophoresis in 1% agarose gels and blotting onto Hybond 
XL membranes (GE Healthcare). For northern blot analysis, 
RNA samples were electrophoretically separated in formal-
dehyde-containing 1.5% agarose gels and transferred onto 
Hybond XL membranes.
A restriction fragment covering the entire coding region 
of the selectable marker gene aadA was purified by aga-
rose gel electrophoresis using the NucleoSpin Extract II 
kit (Macherey–Nagel) and used as a hybridization probe. 
Hybridization probes against psaB and grft were generated 
by PCR using gene-specific primers (PpsaB_for 5′-CCC 
AGA AAG AGG CTG GCC C-3′ and PpsaB_rev 5′-CCC AAG 
GGG CGG GAA CTG C-3′; Pgrft_for 5′-ATG GGA TCT TCT 
CAT CAT CATC-3′ and Pgrft_rev 5′-TTA ATA TTG TTC 
ATA ATA AAT ATC TAA AGA -3′). The resulting amplifica-
tion products of 550 bp and 420 bp, respectively, were puri-
fied and probes were labelled with α[32P]dCTP by random 
priming (GE Healthcare). Hybridizations were performed 
at 65 °C in Rapid-Hyb buffer (GE Healthcare) according to 
the manufacturer’s protocol.
 Plant Molecular Biology
1 3
Protein isolation, purification and visualization
Total soluble protein was extracted from leaf samples 
homogenized in a buffer (buffer 1) containing 50 mM N-2-
hydroxyethylpiperazin-N′-2-ethanesulfonic acid (HEPES)-
KOH (pH 7.5), 10 mM potassium acetate, 5 mM magnesium 
acetate, 1 mM EDTA, 1 mM dithiothreitol and 1 mM cOm-
plete protease inhibitor (Roche). Alternatively, a published 
extraction buffer (buffer 2: 100 mM Tris, 300 mM NaCl, 
20 mM ascorbic acid, 10 mM sodium metabisulfite; Fuqua 
et al. 2015a, b) was used. Total soluble protein concen-
trations were determined by the Bradford assay (Roche, 
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Karlsruhe, Germany) using known concentrations of bovine 
serum albumin (BSA) as a protein standard.
Extraction and purification protocols for griffithsin from 
tobacco leaves were optimized for yield and purity. Differ-
ent extraction buffers were tested: (1) the standard native 
His-tag purification buffers described by QIAGEN (50 mM 
 NaH2PO4, 300 mM NaCl, cOmplete protease inhibitor with or 
without 1% Triton, including 10 mM imidazole for extraction, 
20 mM imidazole for washing and 250 mM imidazole for elu-
tion; pH 8 with NaOH), and (2) previously published extrac-
tion buffers for griffithsin (Fuqua et al. 2015a, b; 100 mM 
sodium acetate, 300 mM sodium chloride, 20 mM ascorbic 
acid, 10 mM sodium metabisulfite, with or without 100 mM 
 MgCl2, pH 4 or 6 with HCl; or 100 mM Tris, 300 mM sodium 
chloride, 20 mM ascorbic acid, 10 mM sodium metabisulfite, 
with or without 100 mM  MgCl2, pH 8 with HCl). When used 
for His-tag-based purification, the buffers were modified by 
inclusion of 10 mM imidazole for extraction. The pH 8 buffer 
was modified by including 20 mM imidazole for washing and 
250 mM imidazole for elution.
For extraction, leaves were frozen in liquid nitrogen, 
ground and suspended in 200 µL of extraction buffer per 
100 mg of material. For dried leaves, 2900 µL buffer were 
added per 100 mg material. The suspension was kept on 
ice and vortexed every 5 min, followed by centrifugation 
at 15,000×g for a total of 15 min at 4 °C. Alternatively, the 
suspension was incubated under shaking (Eppendorf Ther-
moMixer comfort) at 700 or 1400 rpm for 15 min at 70 °C 
followed by centrifugation at 15,000×g for 15 min at 4 °C, 
16 °C or 22 °C, or the suspension was centrifuged for 15 min 
and the supernatant heated for 15 min at 70 °C under shak-
ing at 700 or 1400 rpm, followed by a second centrifugation 
step of 15 min at 15,000×g at 4 °C. The supernatant from 
the heat-treated samples was used for His-tag-based protein 
purification via Ni–NTA Agarose (QIAGEN) following the 
manufacturer’s protocol. 3 mL of Ni–NTA agarose slurry 
were used for purification from approximately 8 g of fresh 
tissue or 1 g of dried tissue (i.e., approximately 25–30 mL 
of leaf extract). Plant extracts in pH 4 buffer were adjusted 
to pH 8 with NaOH prior to mixing with Ni–NTA agarose. 
The Ni–NTA agarose was incubated with the leaf extract 
for 1 h (rotating at 4 °C) and subsequently loaded onto QIA-
GEN Polypropylene Columns (5 mL). The eluate from the 
purification was concentrated and dialyzed into PBS buffer 
(137 mM NaCl, 2.7 mM KCl, 10 mM  Na2HPO4, pH 7.4) 
by ultrafiltration with Amicon ® Ultra-4 centrifugal filters 
(Merck) with a 3000 NMWL cut-off, reducing the sample to 
approximately one-tenth of the original volume. The concen-
tration of ultrafiltrated griffithsin samples was determined 
with the Pierce BCA Protein Assay Kit (Thermo Fisher Sci-
entific) using a dilution standard of BSA and recombinant 
6xHis-tagged griffithsin (purified from E. coli; NIH AIDS 
Research & Reference Reagent Program, Germantown, MD) 
as reference proteins.
To visualize accumulation, extraction efficiency and 
purity, protein extracts were electrophoretically separated 
in 10% Tris-Tricine/SDS polyacrylamide gels (Schägger and 
von Jagow 1987), and either directly visualized by Coomas-
sie blue staining or silver staining, or transferred to Hybond-
P PVDF membranes (GE Healthcare) with transfer buffer 
(192 mM glycine, 25 mM Tris, pH 8.3) in a Trans-Blot cell 
(Bio-Rad) for 2 h at 1 A. Blots were blocked with 3% BSA 
and immunodetection was performed with a griffithsin-
specific antibody (NIH AIDS Research & Reference Rea-
gent Program) and goat anti-rabbit IgG antibody peroxidase 
conjugate (Agrisera) as secondary antibody. Detection was 
performed with an enhanced chemiluminescence system 
(ECL® PLUS; GE Healthcare). Recombinant histidine-
tagged griffithsin from E. coli was used as reference.
Fig. 1  Generation of transplastomic tobacco plants expressing the 
anti-HIV protein griffithsin. a Physical maps of the targeted region 
in the tobacco plastid genome (Nt-ptDNA) and the transgenic plas-
tid genomes in Nt-grft and Nt-grft-mf lines. The transgenes are tar-
geted to the intergenic region between two plastid tRNA genes, 
trnfM and trnG (Zhou et al. 2008). Expression of the grft transgene 
is driven by the plastid rRNA operon promoter fused to the gene10 
leader sequence of coliphage T7 and the 3′ UTR of the plastid rbcL 
gene. The aadA expression cassette consists of a chimeric plas-
tid rRNA operon promoter and the 3′ UTR of the psbA gene (Svab 
and Maliga 1993). The expected sizes of the DNA fragments in 
RFLP analyses with the restriction enzyme BamHI are given below 
each map. The location of the hybridization probe is indicated as a 
black bar. b RFLP analysis of transplastomic Nt-grft and Nt-grft-mf 
plants. DNA samples were digested with BamHI and hybridized to 
a radiolabelled probe detecting the plastid genome region flanking 
the transgene insertion site. The homoplasmic state was evidenced 
by absence of the 4.5  kb fragment characteristic of the wild-type 
plastid genome and detection of the 6.8 kb fragment specific to the 
transformed plastid genome. Successful post-transformation excision 
of the aadA gene (Zhou et  al. 2008) and generation of marker-free 
griffithsin-expressing transplastomic plants (Nt-grft-mf) was initially 
assayed with the psaB probe (detecting a 5.4 kb fragment) and fur-
ther confirmed by hybridization to an aadA-specific probe (which 
exclusively detected the expected 6.8 kb fragment in the marker gene-
containing Nt-grft plants). Wt wild type. c Inheritance assay and iden-
tification of marker-free transplastomic lines. Germination of the T1 
generation of Nt-grft plastid transformants in the presence of spec-
tinomycin revealed homoplasmic presence of the selectable marker 
gene aadA. While wild-type seedlings emerge white in the presence 
of the antibiotic, all seedlings of transplastomic plants are uniformly 
resistant to spectinomycin. The progeny of Nt-grft plants crossed to 
nuclear-transgenic plants expressing a plastid-targeted Cre recombi-
nase (Nt-grft-2 × Cre) segregates into 50% fully green seedlings (due 
to hemizygous presence of the cre recombinase gene in the paren-
tal line), variegated and completely white seedlings in the presence 
of spectinomycin. The white seedlings, expected to be completely 
devoid of the aadA marker, were rescued by transfer to antibiotic-
free medium, subsequently grown to maturity in the greenhouse and 
pollinated with wild-type pollen. Uniformly white appearance of the 
progeny (Nt-grft-mf) upon germination on spectinomycin-containing 
medium confirmed the complete removal of the aadA marker
◂
 Plant Molecular Biology
1 3
Determination of anti‑HIV activity of purified 
griffithsin
HIV-1 BaL neutralization assays were performed accord-
ing to published procedures (Wei et al. 2003; Montefiori 
2005). 200 TCID50 (median tissue culture infective dose) 
of HIV-1 BaL were incubated with dilutions of purified grif-
fithsin produced in tobacco or E. coli for 1 h at 37 °C in a 
total volume of 100 µL. Tobacco- and E. coli-produced grif-
fithsin were titrated fivefold seven times in triplicate starting 
at 2 µg/mL. All dilutions were performed in growth medium 
(DMEM) supplemented with 10% foetal calf serum (FCS), 
penicillin–streptomycin (100 units/mL and 100 µg/mL, 
respectively) and 2 mM L-glutamine. The mixture was then 
added to 100 µL of TZM-bl cells expressing CD4, CCR5 
and the firefly luciferase gene under the control of the HIV 
long-terminal repeat sequence and grown in medium pre-
seeded at a concentration of 1 × 105 cells/mL. A positive 
control (cells plus virus) and a cell-only background control 
were also included. After a 24 h incubation at 37 °C in 5% 
 CO2 followed by addition and incubation with lysis buffer, 
the cell lysate was removed and mixed in a 1:1 ratio with 
Bright Glo reagent (Promega) in a 96-well black solid plate 
for luminescence measurements. The percentage reduction 
in relative light units (RLU) was calculated relative to the 
RLU of the positive control (cells plus virus). The resulting 
curve was plotted and analyzed in GraphPad Prism (https ://
www.graph pad.com/).
Results
Stable transformation of the tobacco plastid 
genome with a griffithsin expression cassette
To test whether the anti-HIV protein griffithsin can be 
expressed from the chloroplast genome to high levels, the 
sequence of the griffithsin gene (grft) was codon optimized 
by adjusting it to the preferred codon usage in the tobacco 
plastid DNA (Shimada and Sugiura 1991). To facilitate 
protein purification, an N-terminal histidine tag  (His6) 
was added to the coding region (NCBI accession number 
AY744144.1). The synthetic gene construct was inserted 
into an expression cassette consisting of the ribosomal RNA 
operon promoter (Prrn) fused to the strong translation ini-
tiation signals derived from the gene10 leader of coliphage 
T7 (Kuroda and Maliga 2001; see Materials and Methods). 
The griffithsin cassette was then integrated into a standard 
plastid transformation vector (Zhou et al. 2008) containing a 
chimeric spectinomycin resistance gene (aadA) as selectable 
marker. In this vector, the aadA gene is flanked by loxP sites 
to facilitate post-transformation removal of the antibiotic 
resistance marker (Fig. 1a; Corneille et al. 2001).
Biolistic plastid transformation experiments in tobacco 
were followed by selection for resistance to spectinomycin 
(Svab and Maliga 1993). Primary spectinomycin-resistant 
clones (Nt-grft lines) were subjected to additional rounds of 
selection and regeneration to dilute out residual wild-type 
copies of the highly polyploid plastid genome and isolate 
homoplasmic transplastomic tissue. Successful transforma-
tion and correct targeting of the grft and aadA transgenes to 
the intergenic spacer separating the trnfM and trnG genes by 
homologous recombination was analyzed by restriction frag-
ment length polymorphism (RFLP) analysis using South-
ern blotting (Fig. 1a, b). The results showed the expected 
hybridization patterns in RFLP analyses with either a probe 
derived from a neighboring gene in the plastid genome or a 
probe recognizing the aadA marker gene (Fig. 1b). Absence 
of a hybridization signal for the wild type-specific frag-
ment preliminarily suggested that the lines were homoplas-
mic. However, strong exposure of the blots revealed faint 
hybridization signals corresponding to the expected size of 
the wild-type plastid DNA fragment (Fig. 1b, and data not 
shown). Previous work had established that these weak sig-
nals come from so-called promiscuous DNA (plastid-derived 
DNA sequences that are present in the nuclear genome; 
Hager et al. 1999; Ruf et al. 2000).
To ultimately confirm homoplasmy of the Nt-grft lines, 
we conducted large-scale inheritance tests by germinat-
ing T1 seeds on spectinomycin-containing medium (Bock 
2001). No appearance of antibiotic-sensitive seedlings was 
observed in any of the analyzed lines (Fig. 1c, and data not 
shown), indicating that the transplastomic Nt-grft lines are 
homoplasmic.
Selectable marker gene removal 
from transplastomic plants
To increase the public acceptance of the use of transgenic 
plants in biotechnology, the post-transformation removal of 
antibiotic resistance markers is highly desirable. Excision of 
the aadA cassette is also useful to prevent rearrangements 
or deletions in the transformed genome due to unwanted 
homologous recombination between the expression elements 
controlling the aadA cassette (promoter, 5′ UTR and 3′UTR 
sequences) and the resident copies of these expression ele-
ments in the plastid genome (Rogalski et al. 2006).
Use of a loxP-flanked (‘floxed’) version of the aadA 
marker gene in our transformation construct (Fig.  1a) 
allowed excision of the aadA cassette by site-specific recom-
bination triggered by a nucleus-encoded Cre recombinase 
that is post-translationally imported into plastids (Cor-
neille et al. 2001). To this end, we crossed homoplasmic 
transplastomic Nt-grft lines (maternal parent) to a nuclear 
transgenic Cre-expressing line (pollen donor). The progeny 
was raised on spectinomycin-containing medium to identify 
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seedlings whose plastid genome was devoid of the aadA 
gene due to Cre-mediated excision from all copies of the 
plastid genome. These seedlings were easily recognizable by 
their spectinomycin-sensitive (pale) phenotype. As expected, 
the progeny segregated into homogeneously pale (complete 
aadA excision), variegated (incomplete aadA excision) and 
green (no or low-level aadA excision) seedlings (Fig. 1c). 
Homogeneously pale seedlings were rescued by transfer to 
antibiotic-free medium, after recovery grown to maturity in 
the greenhouse and then crossed to the wild type (as pollen 
donor) to eliminate the Cre transgene and the linked nuclear 
antibiotic resistance marker (a gentamycin resistance gene; 
Corneille et al. 2001) in the next generation. The resulting 
completely marker-free transplastomic plants (Nt-grft-mf) 
have no nuclear transgene anymore, lack the aadA marker 
in the plastid genome and contain grft as the sole transgene 
(Figs. 1c, 2).
RFLP analyses by Southern blotting and inheritance 
assays ultimately confirmed that the aadA gene had been 
completely excised from all copies of the transgenic plastid 
genome (Fig. 1b, c).
Neither the Nt-grft lines nor the derived marker-free 
Nt-grft-mf lines displayed any obvious phenotypic abnor-
malities. Upon transfer to soil and growth under standard 
greenhouse conditions, all transplastomic plants were 
indistinguishable from wild-type plants (Fig. 2), with 
the exception of a slightly delayed initial development 
(Fig. S1a). However, this was a very subtle phenotype 
that became less obvious with time and had largely disap-
peared after a few weeks of growth (Fig. 2).
Fig. 2  Plant phenotypes upon growth in soil. Plants were raised from 
seeds and photographed 4 weeks (29 days), 6 weeks and 8 weeks 
after germination. A wild-type plant, a transplastomic plant harbor-
ing the grft and aadA transgenes (Nt-grft line), a transplastomic plant 
lacking the aadA marker due to excision by a nucleus-encoded chlo-
roplast-targeted Cre recombinase (also carrying the linked nuclear 
gentamycin resistance marker gent; Nt-grft-cre) and transplastomic 
grft plants without any other transgenes (Nt-grft-mf) are shown. The 
transgenes present in each line are given in parentheses. Scale bars: 
10 cm
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Griffithsin mRNA and protein accumulation 
in transplastomic plants
To test for expression of the introduced grft transgene, we 
first performed northern blot experiments using transgene-
specific probes. Hybridization to a grft probe detected a 
band of the expected size of the mature (monocistronic) grft 
mRNA (0.58 kb; Fig. 3a) and two larger transcript species 
that likely result from read-through transcription and termi-
nation or processing at the loxP site downstream of the grft 
gene, as observed previously with transgenes expressed from 
the same insertion site in the plastid genome (e.g., Zhou 
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et al. 2008). The Nt-grft-mf lines lack a prominent band for 
the largest transcript species seen in the Nt-grft plants, tenta-
tively suggesting that this RNA species originates from ter-
mination or processing within the aadA cassette downstream 
of the grft gene (Figs. 1a, 3a). As expected, the Nt-grft-mf 
lines lack aadA transcripts (Fig. 3a, bottom panel), confirm-
ing complete marker gene removal from all copies of the 
plastid genome.
Having confirmed stable grft mRNA accumulation, we 
next wanted to determine accumulation of the griffithsin 
protein in chloroplasts. To this end, we conducted a series 
of western blot analyses using anti-griffithsin antibodies 
and purified His-tagged griffithsin protein recombinantly 
expressed in E. coli as a standard for protein quantification 
(Fig. 3b–e). Since foreign protein accumulation in transplas-
tomic plants can be strongly dependent on leaf age (e.g., 
Zhou et al. 2008; Oey et al. 2009a, b), we also analyzed a 
developmental series of leaves of different ages harvested 
from young or mature transplastomic plants (Fig. 3b).
Western blot analysis revealed a strong signal for the 
recombinant His-tagged griffithsin protein at the expected 
size of ~ 14.5 kDa in all transplastomic plants (Fig. 3c). 
Comparison of Nt-grft with Nt-grft-mf lines revealed no sig-
nificant differences, indicating that marker excision does not 
impact recombinant protein accumulation (Fig. 3c). Analysis 
of Nt-grft leaves of different ages and developmental stages 
also did not show pronounced differences in griffithsin accu-
mulation levels (Fig. 3d). This finding was further confirmed 
by Coomassie staining of protein extracts from Nt-grft-mf 
lines which revealed a strong band for griffithsin in leaves 
of all ages and developmental stages, with the exception of 
the very young leaflets (close to the apical meristem) that 
accumulated substantially lower levels of griffithsin protein 
(Fig. S1).
Quantification of griffithsin accumulation using two dif-
ferent buffers for extraction of total soluble protein (TSP) 
yielded slightly different values, presumably because one 
of the buffers (buffer 1) was less efficient in extraction of 
griffithsin from leaf material, as also suggested by incom-
plete denaturation of the griffithsin dimers into monomers 
(Fig. 3e). Following extraction with the more effective 
buffer 2, griffithsin was detected at approximately 5% of 
TSP (Fig. 3e), which represents an extraordinarily high accu-
mulation level, given the small size of the protein.
Purification of griffithsin from transplastomic 
tobacco plants
Having achieved high levels of griffithsin accumulation in 
transplastomic plants, we next attempted purification of the 
protein to (i) be able to determine its biological activity as 
antiviral agent, and (ii) test if transplastomic plants provide 
a suitable production platform for the large-scale synthesis 
and isolation of pure griffithsin as biopharmaceutical. Due to 
its physicochemical properties and, in particular, its excep-
tionally high thermal stability, griffithsin can be enriched by 
heating total protein extracts which results in the denatura-
tion and precipitation of most other cellular proteins (Fuqua 
et al. 2015a, b).
If strong enrichment by heat treatment of crude protein 
extracts of transplastomic plants can be achieved, the high 
levels of griffithsin accumulating in our transplastomic 
tobacco plants should result in the protein becoming readily 
detectable in Coomassie-stained polyacrylamide (PAA) gels. 
Indeed, heating of leaf protein extracts to 70 °C resulted in 
loss of nearly all abundant cellular proteins and retention 
of a single prominent band that corresponds in size to grif-
fithsin (Fig. 4a). Testing of a number of different extraction 
buffers revealed that buffer composition also had an impact 
on the efficiency of pre-purification and the abundance and 
pattern of residual contaminants (Fig. 4a).
We then attempted purification taking advantage of the 
His-tag that had been included in the griffithsin expression 
construct. Based on the strong enrichment that had been 
obtained by sample heating (Fig. 4a), further purification 
to apparent homogeneity by nickel affinity purification was 
readily achieved (Fig. 4b), providing suitable material for 
Fig. 3  Expression of griffithsin in transplastomic tobacco plants. a 
Accumulation of grft and aadA transcripts. The grft-specific probe 
detects three major transcript species in Nt-grft plants (~ 0.92, ~ 0.62, 
~ 0.58  kb) and two major transcripts in Nt-grft-mf plants (~ 0.62, 
~ 0.58  kb), a pattern observed for the pKP9 expression cassette in 
previous studies (e.g., Zhou et al. 2008). The ~ 1 kb aadA transcript 
accumulates in Nt-grft plants, but is not detectable in the wild type 
(Wt) and in marker gene-free plants (Nt-grft-mf). The ethidium bro-
mide-stained 25S rRNA of the cytosolic 80S ribosomes served as a 
loading control. b A transplastomic plant (Nt-grft-2) and a wild type 
grown under standard greenhouse conditions for six (young) and 
eight (mature) weeks to illustrate the sampling of leaves (consecu-
tively numbered from the bottom to the top of the plant) for immu-
noblot analyses. Scale bar: 5 cm. c Accumulation of the griffithsin 
(Grft) protein in seedlings. The griffithsin-specific antibody detects 
a protein of the expected size (14.5  kDa) in total soluble protein 
extracts (5 µg loaded per lane) of all transplastomic plants. Immuno-
detection of RbcL served as loading control. d Comparison of grif-
fithsin accumulation in a developmental series of leaves. Immunode-
tection of griffithsin in total soluble protein extracts (5 µg per sample) 
of three different leaves from a young plant (leaves number 7, 6 and 
5) and four leaves from a mature plant (leaves 12, 10, 8 and 6). e 
Determination of griffithsin accumulation levels in total soluble pro-
tein (TSP) samples. TSP was extracted with two different buffers (see 
“Materials and methods”) from the wild type (Wt) and the Nt-grft-
mf-2 line (G). Two replicates per buffer and plant line were analy-
ses. For buffer 1, samples of 10 µg TSP and for buffer 2, samples of 
2.5 µg TSP were loaded. Immunodetection of RbcL served as loading 
control. In buffer 1, the griffithsin dimer is detected and RbcL shows 
larger complexes, suggesting incomplete protein denaturation. Using 
known standards of recombinant histidine-tagged griffithsin, griffith-
sin was detected at approximately 2% of TSP with buffer 1 (including 
the dimer) and approximately 5% with buffer 2
◂
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activity tests and yielding approximately 360 µg pure grif-
fithsin per gram fresh weight.
Anti‑HIV activity of chloroplast‑expressed griffithsin
To determine whether griffithsin extracted from transplas-
tomic tobacco plants is biologically active and can prevent 
entry of HIV-1 into human cells, virus neutralization tests 
were performed (Wei et al. 2003; Montefiori 2005). To 
this end, cultured HeLa cells containing a HIV-inducible 
luciferase gene were incubated with viral particles in the 
presence of different concentrations of griffithsin puri-
fied from tobacco leaves. These assays revealed efficient 
virus neutralization by the chloroplast-produced griffithsin 
that was very similar to the activity of recombinant grif-
fithsin purified from E. coli (Fig. 5a). These data indicate 
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that transplastomic expression of griffithsin results in large 
amounts of protein that is fully active and displays high anti-
viral activity.
Purification of active griffithsin from dried tobacco
To facilitate rapid scale-up of the production of plant-based 
biopharmaceuticals, it is desirable to be able to store the 
raw material (plant biomass) for a longer period of time. 
This removes the need to respond to increasing demands 
by producing large amounts of plant biomass, which repre-
sents the most time-consuming step in the production pro-
cess. The long-term storage procedure used in the tobacco 
industry relies on drying of the harvested leafy biomass. 
We, therefore, wanted to test whether chloroplast-synthe-
sized griffithsin would remain stable upon drying and dur-
ing storage, and retain its biological activity. We, therefore, 
dried leaves harvested from transplastomic griffithsin-pro-
ducing plants and stored them at room temperature for up to 
10 months after harvest. Afterwards, proteins were extracted 
Fig. 4  Comparison of seven different extraction buffers and three han-
dling methods for griffithsin extraction, purification and concentration. 
a Coomassie blue-stained Tris-Tricine SDS polyacrylamide gel (10%). 
Buffer A: 100  mM sodium acetate, 300  mM NaCl, 20  mM ascorbic 
acid, 10 mM sodium metabisulfite, pH 4 (Fuqua et al. 2015a, b). Buffer 
B: 100  mM sodium acetate, 300  mM NaCl, 20  mM ascorbic acid, 
10 mM sodium metabisulfite, pH 6 (Fuqua et al. 2015a, b). Buffer C: 
100 mM Tris, 300 mM NaCl, 20 mM ascorbic acid, 10 mM sodium 
metabisulfite, pH 8 (Fuqua et al. 2015a, b). Buffer D: 50 mM  NaH2PO4, 
300 mM NaCl, 10 mM imidazole, pH 8 (QIAGEN, 6xHis-tag purifica-
tion buffer). Buffer E: buffer D with 1% Triton X-100. Buffer F: Buffer 
A with 0.1 M  MgCl2. Buffer G: Buffer C with 0.1 M  MgCl2. 1× com-
plete EDTA-free protease inhibitor (Roche) was included in all buffers. 
Handling method 1: ground leaf material was incubated for 15 min in 
the extraction buffer on ice with vortexing every 5  min, followed by 
centrifugation (15 min, 15,000×g, 4 °C). Handling method 2: Ground 
leaf material was heated in the extraction buffer at 70  °C for 15 min 
under shaking at 1400  rpm, followed by centrifugation (15,000×g, 
4  °C). Handling method 3: ground leaf material in extraction buffer 
was centrifuged at 15,000×g at 4  °C, followed by incubation of the 
supernatant at 70 °C for 15 min under shaking at 1400 rpm, followed 
by a second centrifugation step at 15,000×g at 4 °C. Wt wild type. b 
Silver-stained SDS polyacrylamide gel (10%) illustrating different puri-
fication methods. Extraction was performed with wild-type plants (W) 
and griffithsin-producing transplastomic plants (G) to test the effect of 
different buffers in combination with heating on the abundance of con-
taminants. E in the sample designation indicates eluate (from His-tag-
based purification), C indicates the concentrated sample (by ultrafiltra-
tion; see “Materials and methods”). The loaded sample volumes were 
adjusted to allow for direct comparison of protein purity and assess-
ment of protein loss. Abundant bands are marked at the right: contami-
nants (c), griffithsin (G), griffithsin dimer (dG). The ‘pH 8’ purification 
was performed in QIAGEN 6xHis-tag purification buffer supplemented 
with 10 mM imidazole for extraction, 20 mM imidazole for washing 
and 250  mM imidazole for elution (E). The ‘pH 4’ purification was 
performed in an extraction buffer (buffer A in a) supplemented with 
10 mM imidazole. Washing and elution were done in buffer C (cf. a), 
supplemented with 20 mM imidazole for washing and 250 mM imida-
zole for elution. The ‘pH 4,  MgCl2’ purification is similar to the ‘pH 4’ 
purification, but includes 100 mM  MgCl2 in all buffers. Eluates were 
dialyzed and concentrated (C) in PBS buffer. Note that pH 4 extrac-
tion effectively reduced contaminations, and yielded 360  µg solu-
ble griffithsin per gram leaf material. Extraction with ‘pH 4,  MgCl2’ 
yielded slightly more griffithsin with a similar purity, but slightly lower 
amounts of griffithsin were recovered after ultrafiltration
◂
Fig. 5  HIV neutralization assays to determine the biological activity 
of chloroplast-produced griffithsin. a HIV neutralization was com-
pared between recombinant griffithsin produced in E. coli (Grft E. 
coli), wild-type tobacco protein extracts (Wt N.t. pH 8) and griffith-
sin purified from transplastomic tobacco with either His-tag purifica-
tion buffer (Grft N.t. pH 8) or with ‘pH 4’ buffer (Grft N.t. pH 4; cf. 
Fig. 4). As an additional negative control, an anti-rabies monoclonal 
antibody (‘unrelated mAb’) was used. Error bars indicate the SD 
from three technical replicates for each experiment. b HIV neutraliza-
tion assay comparing griffithsin extracted from freshly frozen tobacco 
leaves with griffithsin extracted from dried tobacco. As an additional 
control, extracts from dried wild-type tobacco leaves (Wt N.t. dry pH 
4) were also included. c IC50 values for the different extracts repre-
senting three IC50 measurements from three experimental repeats of 
the HIV neutralization assay with griffithsin purified from E. coli and 
frozen tobacco leaves, and five IC50 measurements from two experi-
mental repeats for griffithsin purified from dried tobacco leaves
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and purification of griffithsin was attempted. Immunob-
lot analysis of total soluble protein extracts revealed high 
recovery of full-length griffithsin from dried tobacco and no 
evidence of appreciable protein degradation during drying 
or long-term storage (Fig. 6a).
Purification of griffithsin from dried tobacco was 
slightly less efficient than protein purification from fresh 
or frozen leaf material (Fig. 6b). Importantly, griffithsin 
purified from dried tobacco retained high anti-HIV activity 
in virus neutralization assays (Fig. 5b, c), demonstrating 
that dried leaf biomass facilitates long-term storage and 
provides suitable source material for extraction of griffith-
sin upon demand.
Discussion
In the course of this work, we have investigated the pos-
sibility to produce the potent anti-HIV protein griffithsin in 
tobacco chloroplasts. Previous attempts to synthesize cyano-
virin-N, a longer known but less potent anti-HIV protein, in 
trangenic chloroplasts had met with limited success (Elghabi 
et al. 2011). Cyanovirin-N turned out to be rather unstable 
in chloroplasts and, although protein accumulation could be 
improved by fusion to N- and/or C-terminal sequences taken 
from highly stable proteins, accumulation levels remained 
relatively low (Elghabi et al. 2011). By contrast, griffithsin, 
a protein of similar size but unrelated in primary amino acid 
sequence, accumulated in transplastomic tobacco plants to 
levels of up to 5% of TSP (Fig. 3). Considering the small 
size of the recombinant protein (of only 14.5 kDa), this is 
an exceptionally high expression level that suggests that, 
unlike cyanovirin-N, griffithsin is highly stable in transgenic 
chloroplasts. It is important to note that the same expres-
sion elements were used for the transplastomic expression 
of cyanovirin-N and griffithsin, suggesting that the strong 
difference in protein accumulation is due to differences in 
protein stability. Why griffithsin is so much more stable than 
cyanovirin-N is currently unclear. Although some determi-
nants of chloroplast protein (in)stability have recently been 
uncovered (Apel et al. 2010; De Marchis et al. 2012; Row-
land et al. 2015), we are still far from being able to explain 
why certain proteins are less stable than others (let alone to 
predict the stability of foreign proteins to be expressed in 
plastids).
Chloroplast-produced griffithsin could be easily purified 
to apparent homogeneity. The purified protein displayed high 
HIV-neutralizing activity and showed no evidence of cyto-
toxicity in bioassays with HeLa cells (Fig. 5), suggesting that 
transplastomic plants can provide a cost-effective and eas-
ily scalable production platform for this important antiviral 
agent. In the absence of an AIDS vaccine, microbicides that 
prevent new viral infections are likely to become an impor-
tant part of future anti-HIV strategies (and perhaps, also of 
strategies to control other viruses that griffithsin binds to; 
O’Keefe et al. 2010; Barton et al. 2014).
Fig. 6  Extraction of griffithsin from dried tobacco leaves. a Western 
blot analysis of griffithsin accumulation in dried leaves. TSP was 
extracted from frozen or dried leaves of griffithsin-producing trans-
plastomic (G) and wild-type plants (W). Leaves that had been dried 
and stored for 4 months were compared to leaves that had been fro-
zen and stored at − 80  °C until use. 200  µL buffer were added per 
100  mg ground frozen leaf material. To compensate for water loss, 
29 µL/mg buffer were added to ground dried leaf material. All extrac-
tions were performed with ‘pH 4’ buffer with an incubation step at 
either 22 or 70 °C for 15 min. The effect of freezing the dried tobacco 
samples in liquid nitrogen before grinding (N) was also tested. Grif-
fithsin and its dimer were immunodetected with a griffithsin-specific 
antibody. b Silver-stained SDS-PAA gel (10%) illustrating the purifi-
cation of griffithsin from dried leaves. Extraction was performed as 
in a. The eluate (e) was ultrafiltrated resulting in a color gradient of 
an upper light-colored fraction (cl) and a more dark-colored lower 
fraction (cd). 500 ng of 6xHis-tagged griffithsin purified from E. coli 
was loaded as a reference (G500). The loaded eluate volumes were 
adjusted to allow for quantitative comparison of input and eluate
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In this work, we also explored the possibility to use dry 
tobacco as storable material for recombinant protein puri-
fication on demand. Interestingly, griffithsin remained sta-
ble during drying and long-term storage and retained high 
antiviral activity (Figs. 5, 6). The IC50 value of griffith-
sin extracted from dry tobacco is slightly higher than that 
of griffithsin purified from fresh biomass or from E. coli 
(Fig. 5c). The reason for this difference is currently unknown 
and could be related to some activity loss upon drying and/
or storage or, alternatively, lower purity of the protein sam-
ples due to the different starting material and/or differences 
in sample preparation (leading to an overestimation of 
the griffithsin concentration and thus giving lower appar-
ent activity). Nonetheless, similar to rice grains (Vamvaka 
et al. 2016), dried tobacco leaves provide an attractive option 
for long-term storage of large amounts of raw material for 
griffithsin extraction upon demand. This is of particular 
importance to the potential use of griffithsin in the develop-
ing world, where the demand for anti-HIV microbicides is 
greatest. Although griffithsin can be expressed also to high 
levels by transient transformation of fresh biomass (O’Keefe 
et al. 2009), the procedures involved are too complicated and 
demanding to be implemented locally.
In summary, our work reported here demonstrates the 
feasibility of using transplastomic plants as highly efficient 
and cost-effective production platform for griffithsin, the 
currently most promising anti-HIV agent. Moreover, we 
have shown that dried tobacco can serve as source material 
for purification of griffithsin, thus enabling quick scale-up 
of production and rapid response to increasing demands.
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